8-K current report · filed Oct 30, 2026

ACTUATE THERAPEUTICS, INC. (ACTU) 8-K Current Report: October 30, 2026

Item 3.01ACTU overview

Short answer

ACTUATE THERAPEUTICS, INC. (ACTU) filed an 8-K current report with the SEC on October 30, 2026 reporting Item 3.01 (Notice of Delisting). Nasdaq deficiency: ACTU closed below the $1.00 minimum bid for 30 consecutive business days.

  • This filing includes Item 3.01, an item that often signal trouble.

Why these 8-K items matter →

ACTUATE THERAPEUTICS, INC. 8-K event analysis

AI summary of each reported item and its exhibits

Item 3.01 · Notice of Delisting

  • Nasdaq deficiency: ACTU closed below the $1.00 minimum bid for 30 consecutive business days
  • No immediate delisting: Common stock continues trading on Nasdaq Global Market under ACTU
  • Initial cure period ends April 26, 2027, requiring a closing bid of at least $1.00 for 10 consecutive business days
  • Separate MVLS deficiency remains unresolved, with compliance required by January 11, 2027
  • Failure to cure could trigger delisting, though Nasdaq Capital Market transfer may provide a second 180-day period

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other ACTUATE THERAPEUTICS, INC. 8-K filings

Get the next ACTU 8-K as it lands

Follow ACTU for push alerts, or ask the research agent what this filing means.